Occurrence of systemic lupus erythematosus in a Danish community: An 8-year prospective study

Scandinavian Journal of Rheumatology

Volumn 38, Issue 2, 2009, Pages 128-132

  Laustrup, H ^a   Voss, A ^a   Green, A ^a,b   Junker, P ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; COHORT ANALYSIS; COMMUNITY; DENMARK; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CHILD; DENMARK; DISEASE PROGRESSION; FEMALE; HUMANS; INCIDENCE; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES; REGISTRIES; YOUNG ADULT;

EID: 62249108610     PISSN: 03009742     EISSN: 15027732     Source Type: Journal    
DOI: 10.1080/03009740802419073     Document Type: Article

References (26)

1. Hochberg MC. Systemic lupus erythematosus. Rheum Dis Clin North Am 1990;16:617-39.
2. Michet CJ Jr, McKenna CH, Elveback LR, Kaslow RA, Kurland LT. Epidemiology of systemic lupus erythematosus and other connective tissue diseases in Rochester, Minnesota, 1950 through 1979. Mayo Clin Proc 1985;60:105-13.
3. Hochberg MC, Perlmutter DL, Medsger TA, Steen V, Weisman MH, White B, et al. Prevalence of self-reported physician-diagnosed systemic lupus erythematosus in the USA. Lupus 1995;4:454-6.
4. Jonsson H, Nived O, Sturfelt G. Outcome in systemic lupus erythematosus: a prospective study of patients from a defined population. Medicine (Baltimore) 1989;68:141-50.
5. Petri M. The effect of race on incidence and clinical course in systemic lupus erythematosus: The Hopkins Lupus Cohort. J Am Med Women's Assoc 1998;53:9-12.
6. Voss A, Green A, Junker P. Systemic lupus erythematosus in Denmark: clinical and epidemiological characterization of a county-based cohort. Scand J Rheumatol 1998;27:98-105.
7. Staahl-Hallengren C, Jonsen A, Nived O, Sturfelt G. Incidence studies of systemic lupus erythematosus in Southern Sweden: increasing age, decreasing frequency of renal manifestations and good prognosis. J Rheumatol 2000;27:685-91.
8. Nossent HC. Systemic lupus erythematosus in the Arctic region of Norway. J Rheumatol 2001;28:539-46.
9. Alamanos Y, Voulgari PV, Siozos C, Katsimpri P, Tsintzos S, Dimou G, et al. Epidemiology of systemic lupus erythematosus in northwest Greece 1982-2001. J Rheumatol 2003;30:731-5.
10. Chakravarty EF, Bush TM, Manzi S, Clarke AE, Ward MM. Prevalence of adult systemic lupus erythematosus in California and Pennsylvania in 2000: estimates obtained using hospitalization data. Arthritis Rheum 2007;56:2092-4.
11. Statistics Denmark www.dst.dk/homeuk.aspx
12. Fries JF, Holman HR. Systemic lupus erythematosus: a clinical analysis. Major Probl Intern Med 1975;6:v-199.
13. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
14. Hook EB, Regal RR. Capture-recapture methods in epidemiology: methods and limitations. Epidemiol Rev 1995;17:243-64.
15. Green A, Stovring H, Andersen M, Beck-Nielsen H. The epidemic of type 2 diabetes is a statistical artefact. Diabetologia 2005;48:1456-8.
16. Trager J, Ward MM. Mortality and causes of death in systemic lupus erythematosus. Curr Opin Rheumatol 2001;13:345-51.
17. From the Centers for Disease Control and Prevention. Trends in deaths from systemic lupus erythematosus - United States, 1979-1998. J Am Med Assoc 2002;287:2649-50.
18. Abu-Shakra M, Gladman DD, Urowitz MB. Mortality studies in SLE: how far can we improve survival of patients with SLE. Autoimmun Rev 2004;3:418-20.
19. Cervera R, Khamashta MA, Font J, Sebastiani GD, Gil A, Lavilla P, et al. Morbidity and mortality in systemic lupus erythematosus during a 5-year period. A multicenter prospective study of 1,000 patients. European Working Party on Systemic Lupus Erythematosus. Medicine (Baltimore) 1999;78:167-75.
20. Chun BC, Bae SC. Mortality and cancer incidence in Korean patients with systemic lupus erythematosus: results from the Hanyang lupus cohort in Seoul, Korea. Lupus 2005;14:635-8.
21. Moss KE, Ioannou Y, Sultan SM, Haq I, Isenberg DA. Outcome of a cohort of 300 patients with systemic lupus erythematosus attending a dedicated clinic for over two decades. Ann Rheum Dis 2002;61:409-13.
22. Greer JM, Panush RS. Incomplete lupus erythematosus. Arch Intern Med 1989;149:2473-6.
23. Swaak AJ, van den Brink HG, Smeenk RJ, Manger K, Kalden JR, Tosi S, et al. Systemic lupus erythematosus. Disease outcome in patients with a disease duration of at least 10 years: second evaluation. Lupus 2001;10:51-8.
24. Vila LM, Mayor AM, Valentin AH, Garcia-Soberal M, Vila S. Clinical outcome and predictors of disease evolution in patients with incomplete lupus erythematosus. Lupus 2000;9:110-15.
25. Ganczarczyk L, Urowitz MB, Gladman DD. 'Latent lupus'. J Rheumatol 1989;16:475-8.
26. Staahl-Hallengren HC, Nived O, Sturfelt G. Outcome of incomplete systemic lupus erythematosus after 10 years. Lupus 2004;13:85-8.